Is SI or SRTA more profitable?

SRTA runs the higher net margin — SI at -58.33% versus SRTA at 15.71%.

Shoulder Innovations, Inc. (SI) vs Strata Critical Medical, Inc. (SRTA)

A side-by-side comparison of Shoulder Innovations, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Shoulder Innovations, Inc.

$405M

$19.52HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

SRTA

Strata Critical Medical, Inc.

$411M

$4.76HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — SI vs SRTA

growth of $100 · dividends reinvested · last 1y

SI +30.2% (+30.2%/yr)SRTA +20.6% (+20.6%/yr)SI compounded faster over this window

SI SRTA

SI vs SRTA: by the numbers

•SRTA is the larger company ($411M vs $405M market cap).
•SRTA is profitable (15.71% net margin) while SI runs a net loss (-58.33%).

Metrics side by side

Valuation

Metric	SI	SRTA
P/E ratio	N/A	9.55
P/S ratio	6.74	1.61
P/B ratio	3.26	1.47

Profitability

Metric	SI	SRTA
Gross margin	77.34%	20.56%
Operating margin	-58.53%	-7.97%
Net margin	-58.33%	15.71%
ROE	-28.18%	14.40%
ROIC	-25.26%	-7.11%

Growth (annualized)

Metric	SI	SRTA
Revenue CAGR (5Y)	N/A	46.05%
Total return CAGR (5Y)	N/A	-13.77%

Frequently asked

Is SI or SRTA more profitable?: SRTA runs the higher net margin — SI at -58.33% versus SRTA at 15.71%.

Go deeper

Full SI analysis Full SRTA analysis Interactive comparison tool

Dig into the metrics

Strata Critical Medical P/E ratio Shoulder Innovations ROE Strata Critical Medical ROE Shoulder Innovations operating margin Strata Critical Medical operating margin Shoulder Innovations revenue growth Strata Critical Medical revenue growth Shoulder Innovations free cash flow Strata Critical Medical free cash flow

Shoulder Innovations & Strata Critical Medical appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.